Naoya Kawashima

Shibaura Institute of Technology — Japan

Neuroscience · Life Sciences

20h-index3.5kcitations48works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Neuroscience and Neuropharmacology Research(19), Receptor Mechanisms and Signaling(15), Pain Mechanisms and Treatments(13), Neurotransmitter Receptor Influence on Behavior(10), Neuropeptides and Animal Physiology(10)

Publications48 total

Direct Torque Control for PMSM by Using Flux Sensor
2020· 3 cited
G0400201 Friction Stir Welding of Mild Steel Plates
The Proceedings of Mechanical Engineering Congress Japan·2015Open Access
1407 An investigation of the suitable substrate for synthesizingdiamond by in-liquid plasma chemical deposition
The Proceedings of Conference of Chugoku-Shikoku Branch·2011Open Access
Effect of 20-HETE Inhibition on Infarct Volume and Cerebral Blood Flow after Transient Middle Cerebral Artery Occlusion
Journal of Cerebral Blood Flow & Metabolism·2008· 96 citedOpen Access
AMPA receptor stimulation mediates the antidepressant-like effect of a group II metabotropic glutamate receptor antagonist
Brain Research·2005· 130 cited
Neuropharmacological profiles of antagonists of group II metabotropic glutamate receptors
Neuroscience Letters·2005· 65 cited
MGS0039: a potent and selective group II metabotropic glutamate receptor antagonist with antidepressant-like activity
Neuropharmacology·2003· 250 cited
Neuropharmacological Profile of an Atypical Antipsychotic, NRA0562
CNS Drug Reviews·2003· 4 citedOpen Access
Electrophysiological effects of melanocortin receptor ligands on neuronal activities of monoaminergic neurons in rats
Neuroscience Letters·2003· 27 cited
Cocaine- and amphetamine-regulated transcript peptide produces anxiety-like behavior in rodents
European Journal of Pharmacology·2003· 97 cited
In vitro and in vivo pharmacological profile of 4-(4-fluorobenzylidene)-1-{2-[5-(4-fluorophenyl)-1H-pyrazol-4-yl] ethyl} piperidine (NRA0161)
Life Sciences·2002· 2 cited
In vitro and in vivo pharmacological profile of 5-{2-[4-(6-fluoro-1H-indole-3-yl)piperidin-1-yl]ethyl}-4-(4-fluorophenyl)thiazole-2-carboxylic acid amide (NRA0562), a novel and putative atypical antipsychotic
Life Sciences·2002· 18 cited
Corrigendum to “Neuropharmacological profiles of a novel atypical antipsychotic, NRA0562, in rats” [Eur. J. Pharmacol. 423 (2001) 27–33]
European Journal of Pharmacology·2001
Involvement of the hypothalamus–pituitary–adrenal axis in antidepressant activity of corticotropin-releasing factor subtype 1 receptor antagonists in the rat learned helplessness test
Pharmacology Biochemistry and Behavior·2001· 16 cited
Neuropharmacological profiles of a novel atypical antipsychotic, NRA0562, in rats
European Journal of Pharmacology·2001· 8 cited
Pain threshold, learning and formation of brain edema in mice lacking the angiotensin II type 2 receptor
Life Sciences·2000· 48 cited
Activation of an Effector Immediate‐early Gene<i>arc</i>by Methampetamine
Annals of the New York Academy of Sciences·2000· 24 cited
Effects of selective dopamine D4 receptor blockers, NRA0160 and L-745,870, on A9 and A10 dopamine neurons in rats
Life Sciences·1999· 5 cited
A selective dopamine D4 receptor antagonist, NRA0160: A preclinical neuropharmacological profile
Life Sciences·1999· 28 cited
Receptor Binding, Behavioral, and Electrophysiological Profiles of Nonpeptide Corticotropin-Releasing Factor Subtype 1 Receptor Antagonists CRA1000 and CRA1001
Journal of Pharmacology and Experimental Therapeutics·1999· 153 citedOpen Access
page 1 of 3Next →

Frequent Co-authors

Shigeru Okuyama(23), Shigeyuki Chaki(16), Atsuro Nakazato(11), Kazuyuki Tomisawa(10), Toshihito Kumagai(9), Yutaka Kasuya(9), Yoshiko Suzuki(8), Junzo Kamei(8), Junzo Kamei(6), Tomohiro Omura(5), Takeo Funakoshi(5), Shinichi Ogawa(4), Ryoko Yoshikawa(4), Toshiharu Shimazaki(4), Shigeyuki Chaki(4), Yutaka Kasuya(4), Miwa Misawa(4), Hiroshi Nagase(4), Miwa Misawa(4), Kazuya Kameo(4)